Imran A. Nizamuddin, MD¹, Narendranath Epperla, MD, MS², Mary-Kate Malacek, MD^3*, Brad S. Kahl, MD⁴, Fei Wan, PhD^5*, Anne Fischer, BS^6*, Chaz Moreno^6*, Emily R. King, BA^6*, Anna Krivenko^2*, Nancy L. Bartlett, MD⁷ and Neha Mehta-Shah, MD⁸

¹Division of Oncology, Washington University School of Medicine, St. Louis, MO
²The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
³Missouri Baptist Medical Center, St. Louis, MO
⁴Department of Medicine, Washington University School of Medicine, St. Louis, MO
⁵Division of Public Health Sciences, Washington University School of Medicine, St. Louis, MO
⁶Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
⁷Siteman Cancer Center, Washington University Sch. of Med. Siteman Cancer Center, Saint Louis, MO
⁸Siteman Cancer Center, Washington University School of Medicine, Olivette, MO

Zheng Song^1*, Ying Cheng^2*, Haiyan Yang^3*, Liling Zhang^4*, Liqun Zou^5*, Ye Guo^6*, Junning Cao⁷, Huiqiang Huang, MD, PhD^8*, Zhao Wang^9*, Sha Huang^10*, Yiqian Fang^10*, Jiaoyan Lyu^11*, Keshu Zhou, MD^12* and Huilai Zhang, MD¹³

¹Tianjin Medical University Cancer Hospital and Institute, Tianjin, China
²Jilin Cancer Hospital, Changchun, China
³Department of Hematology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China
⁴Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁵Department of Hematology, West China Hospital of Sichuan University, Chengdu, China
⁶Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China
⁷Fudan University Shanghai Cancer Center, Shanghai, China
⁸Sun Yat-sen University, Guangzhou, China
⁹Beijing Friendship Hospital, Capital Medical University, Beijing, China
¹⁰BeiGene (Shanghai) Co, Ltd, Shanghai, China
¹¹BeiGene (Beijing) Co, Ltd, Beijing, China
¹²Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
¹³Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China

Catherine S. Diefenbach, MD¹, Paolo F. Caimi², Nakhle S Saba, MD³, Fernando Vargas Madueno, MD⁴, Mehdi Hamadani, MD⁵, Luis E. Fayad, MD⁶, Peter A. Riedell, MD^7*, Andrew Gillis-Smith^8*, Stephen Simko^9*, Victor Orellana-Noia^9*, Maria Filippou-Frye^9*, Amy V. Kapp^9*, James Relf^10*, Linda Lundberg^11* and Lauren C. Pinter-Brown^12*

¹Perlmutter Cancer Center at New York University Langone Health, New York, NY
²Cleveland Clinic, Cleveland, OH
³Tulane University School of Medicine, New Orleans, LA
⁴Moffitt Cancer Center at Memorial Healthcare System, Pembroke Pines, FL
⁵Medical College of Wisconsin, Milwaukee, WI
⁶Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷David and Etta Jonas Center for Cellular Therapy, Chicago, IL
⁸University of Massachusetts Memorial Health, Worcester, MA
⁹Genentech, Inc., South San Francisco, CA
¹⁰Roche Products Ltd, Welwyn Garden City, United Kingdom
¹¹F. Hoffmann-La Roche Ltd, Basel, Switzerland
¹²University of California, Irvine, CA

Martin Hutchings, MD, PhD¹, Anna Sureda Balari, MD, PhD², Francesc Bosch^3*, Thomas Stauffer Larsen, MD, PhD^4*, Paolo Corradini, MD⁵, Abraham Avigdor, MD⁶, María José Terol^7*, Antonio Rueda Dominguez^8*, Antonio Pinto^9*, Alan P Skarbnik, MD¹⁰, Raul Cordoba, MD, PhD¹¹, Judit Mészáros Joergensen, MD, PhD^12*, Pier Luigi Zinzani, MD, PhD¹³, Ronit Gurion^14*, Neta Goldschmidt^15*, Wilfred Leung^16*, Donghang Li^17*, James Relf^18*, Maneesh Tandon^18*, Gila Sellam^19* and Giuseppe Gritti, MD, PhD^20*

¹Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
²Clinical Hematology Department, Institut Català d’Oncologia – L’Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain
³University Hospital Vall d'Hebron, Barcelona, Spain
⁴Odense University Hospital, Odense, Denmark
⁵University of Milan and Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
⁶Sheba Medical Center, Ramat Gan and Tel Aviv University, Tel Aviv, Israel
⁷Hospital Clínico Universitario INCLIVA, University of Valencia, Valencia, Spain
⁸Virgen de la Victoria University Hospital, Málaga, Spain
⁹National Cancer Institute Fondazione G. Pascale IRCCS, Naples, Italy
¹⁰Novant Health Cancer Institute, Charlotte, NC
¹¹Fundación Jiménez Díaz University Hospital, Madrid, Spain
¹²Aarhus University Hospital, Aarhus, Denmark
¹³University of Bologna, Bologna, Italy
¹⁴Institute of Hematology, Davidoff Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
¹⁵Department of Hematology, Hadassah Medical Center, Jerusalem, Israel
¹⁶Genentech, Inc., South San Francisco, CA
¹⁷Roche (China) Holding Ltd, Shanghai, China
¹⁸Roche Products Ltd, Welwyn Garden City, United Kingdom
¹⁹F. Hoffmann-La Roche Ltd, Basel, Switzerland
²⁰ASST Ospedale Papa Giovanni XXIII, Bergamo, Italy

Julio C. Chavez, MD¹, Adam J. Olszewski^2*, Mariana Bastos-Oreiro^3*, Sarit E. Assouline, MD⁴, Izidore S. Lossos, MD⁵, Catherine S. Diefenbach, MD⁶, Nilanjan Ghosh^7*, Dipenkumar Modi, MD⁸, Waleed Sabry, MD, MSc. PhD, FRCPE^9*, Seema Naik, MD^10*, Nirav N. Shah, MD¹¹, Ronan Foley, MD, FRCPC^12*, Daniel J Hodson, MD-PhD¹³, Sneha Makadia^14*, Song Pham^15*, Elicia Penuel^14*, Hao Wu^14*, Wahib S. Ead^14*, Iris To^14*, Connie Lee Batlevi¹⁴, Michael C. Wei^14* and L. Elizabeth Budde¹⁶

¹Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Lutz, FL
²Legorreta Cancer Center at Brown University, Lifespan Cancer Institute, Providence, RI
³Hospital General Universitario Gregorio Marañón, Madrid, Spain
⁴Jewish General Hospital, McGill University, Montreal, QC, Canada
⁵University of Miami/Sylvester Comprehensive Cancer Center, Miami, FL
⁶Perlmutter Cancer Center at NYU Langone Health, New York, NY
⁷Levine Cancer Institute/Atrium Health, Charlotte, NC
⁸Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI
⁹Saskatoon Cancer Centre, Saskatoon, SK, Canada
¹⁰Penn State Cancer Institute, Hershey, PA
¹¹Medical College of Wisconsin, Milwaukee, WI
¹²Juravinski Hospital and Cancer Centre, Hamilton, ON, Canada
¹³Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom
¹⁴Genentech, Inc., South San Francisco, CA
¹⁵Hoffmann-La Roche Ltd, Mississauga, ON, Canada
¹⁶City of Hope National Medical Center, Duarte, CA

Martin Hutchings, MD, PhD¹, Michael J. Dickinson, MBBS, DMedSci², Giuseppe Gritti, MD, PhD^3*, Carmelo Carlo-Stella, MD⁴, William Townsend^5*, Francesc Bosch, MD, PhD^6,7, Nancy L. Bartlett, MD⁸, Guillaume Cartron^9*, Herve Ghesquieres, MD, PhD^10*, Roch Houot, MD, PhD^11*, Harriet S. Walter, MD, PhD, MRCP^12*, Fritz Offner, MD, PhD¹³, Natalie Dimier, PhD^14*, Candice Jamois, PharmD^15*, Lance Smith^16*, Sylvia Herter, PhD^17*, Denis Sahin, PhD^18*, Abiraj Keelara, PhD^19*, Koorosh Korfi, PhD²⁰, Jeremy Gallien^19*, Marie-Helene Wasmer^15*, Heather Hinton^21*, Matt Whayman^16*, Isabel Prieto^22*, Georgios Kazantzidis^15*, Katharina Lechner^23* and Franck Morschhauser, MD, PhD²⁴

¹Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
²Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
³Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
⁴IRCCS Humanitas Research Hospital, Humanitas University, ROZZANO, ITA
⁵NIHR Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁶Hematology Department, Hospital Universitario Vall d’Hebron, Barcelona, Spain
⁷Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
⁸Division of Oncology, Washington University School of Medicine, St. Louis, MO
⁹CHU Montpellier, Montpellier, FRA
¹⁰Department of Hematology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France
¹¹CHU Rennes, Univ Rennes, Inserm & EFS, Rennes, France
¹²University of Leicester and University Hospitals Leicester, Leicester, GBR
¹³Universitair Ziekenhuis Ghent, Ghent, Belgium
¹⁴Roche Innovation Center Welwyn, Roche, Welwyn, GBR
¹⁵Pharma Research and Early Development, Roche Innovation Center Basel, Roche, Basel, Switzerland
¹⁶Innovation Center Welwyn, Roche, Welwyn, United Kingdom
¹⁷Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland
¹⁸Product Development Oncology and Hematology, Roche Innovation Center Basel, Roche, Basel, Switzerland
¹⁹Roche Innovation Center, Basel, Switzerland
²⁰Roche Innovation Center Zurich, Roche, Schlieren, -- Select, Switzerland
²¹Product Development, Innovation Center Basel, Roche, Basel, Switzerland
²²Product Development, Innovation Center Welwyn, Roche, Welwyn, United Kingdom
²³Pharma Research and Early Development, Innovation Center Munich, Roche, Penzberg, Germany
²⁴Centre Hospitalier Régional Universitaire de Lille, Lille, France